Title:
【発明の名称】MUC-1抗原に対する治療用抗体およびその使用方法
Document Type and Number:
Japanese Patent JP2003519096
Kind Code:
A
Abstract:
The invention provides therapeutic compositions comprising binding agents that specifically bind to tumor-associated MUC-1 and reduce, reverse or prevent their effects in cancer. More particularly, the invention provides therapeutic compositions that comprise a binding agent that can specifically bind to an epitope that comprises both peptide and carbohydrate on such tumor-associated MUC-1. The invention further provides methods for the use of such therapeutic compositions in the treatment of cancer.
Inventors:
Madhyarakan, Rugpathy
Application Number:
JP2001516562A
Publication Date:
June 17, 2003
Filing Date:
August 18, 2000
Export Citation:
Assignee:
Altarex Corporation
International Classes:
A61K38/00; A61K39/00; A61K39/39; A61K39/395; A61K41/00; A61K45/00; A61K47/48; A61P35/00; C07K16/30; A61K; (IPC1-7): A61K45/00; A61K39/395; A61K47/48; A61P35/00
Foreign References:
WO1994011508A2 | 1994-05-26 | |||
WO1994001773A1 | 1994-01-20 | |||
WO1998033470A2 | 1998-08-06 |
Attorney, Agent or Firm:
Kiyokazu